One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
Status:
Unknown status
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
Patients with ischemic heart disease are often treated with multiple cardiovascular agents,
including aspirin, statins, ezetimibe, Angiotensin Converting Enzyme (ACE) inhibitors or
beta-blockers.
Uncertainty about the optimal timing and clinical implications of administration of
cardiovascular drugs still persists.
The investigators will perform a pilot randomized trial to evaluate the efficacy and safety
of a one daily administration of multiple drugs vs. twice daily administration.